
Honeybell Pharma Private Limited
Pharmaceutical trading company based in Mumbai, established in 2018.
Pharmaceutical trading company based in Mumbai, established in 2018.
Honeybell Pharma Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 November 2018 (Six years and five months 29 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Parekh, Bhavesh Jain, and Ankit Jain serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U74999MH2018PTC316948
316948
Private Limited Indian Non-Government Company
12 Nov 2018
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Honeybell Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Anti Infective Drugs & Medicines, Antibiotic Injection, Anti Infective Agent, Hair Growth Medicine, Sexual Wellness Products, Fertility Enhancer, Cardiovascular Drugs & Medication, Kidney Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjay Parekh ![]() | Additional Director | 01-Apr-2020 | Current |
Bhavesh Jain ![]() | Director | 12-Nov-2018 | Current |
Ankit Jain ![]() | Additional Director | 29-Sep-2020 | Current |
Honeybell Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1864.44% increase. The company also saw a substantial improvement in profitability, with a 326.81% increase in profit. The company's net worth Soared by an impressive increase of 3830.19%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Honeybell Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sanjay Parekh is a mutual person
Sanjay Parekh is a mutual person
Sanjay Parekh is a mutual person
Sanjay Parekh and Bhavesh Jain are mutual person
Sanjay Parekh is a mutual person
Sanjay Parekh and Bhavesh Jain are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Honeybell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Honeybell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Honeybell Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Honeybell Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Honeybell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ankit Kumar Lalit Kumar Jain was appointed as a Additional Director was appointed as a Additional Director on 29 Sep 2020 & has been associated with this company since 4 years 7 months .
Sanjay Sampatraj Parekh was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2020 & has been associated with this company since 5 years 1 month .
Bhavesh Prakash Jain was appointed as a Director was appointed as a Director on 12 Nov 2018 & has been associated with this company since 6 years 5 months .
Honeybell Pharma Private Limited was registered on 12 Nov 2018 with Roc Mumbai & aged 6 years 5 months as per MCA records.
Honeybell Pharma Private Limited was incorporated on 12 Nov 2018.
The authorized share capital of Honeybell Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.30 M.
Currently 3 directors are associated with Honeybell Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Honeybell Pharma Private Limited is 82/90 Ground Floor Anandbhavan Kalbadevi Shamaldas Gandhi Marg Lohar Chawl, India, Mumbai, Maharashtra, 400002.
The corporate identification number (CIN) of Honeybell Pharma Private Limited is U74999MH2018PTC316948 and the company number is 316948 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Honeybell Pharma Private Limited has risen by 1864.44%.
The financial reports for the fiscal year 2020 indicates that The net worth of Honeybell Pharma Private Limited has experienced an upsurge of 3830.19%.
The most recent Balance Sheet for Honeybell Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
NT
NJ